These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16176259)

  • 1. Antiplasmin: the forgotten serpin?
    Coughlin PB
    FEBS J; 2005 Oct; 272(19):4852-7. PubMed ID: 16176259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.
    Law RH; Sofian T; Kan WT; Horvath AJ; Hitchen CR; Langendorf CG; Buckle AM; Whisstock JC; Coughlin PB
    Blood; 2008 Feb; 111(4):2049-52. PubMed ID: 18063751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural heterogeneity of α2-antiplasmin: functional and clinical consequences.
    Abdul S; Leebeek FW; Rijken DC; Uitte de Willige S
    Blood; 2016 Feb; 127(5):538-45. PubMed ID: 26626994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
    Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
    J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice.
    Gonias SL; Fuchs HE; Pizzo SV
    Thromb Haemost; 1982 Oct; 48(2):208-10. PubMed ID: 6758181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA
    Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.
    Hevessy Z; Patthy A; Kárpáti L; Muszbek L
    Thromb Res; 2000 Aug; 99(4):399-406. PubMed ID: 10963790
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification of human alpha 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide.
    Lee SC; Lee KN; Schwartzott DG; Jackson KW; Tae WC; McKee PA
    Prep Biochem Biotechnol; 1997 Nov; 27(4):227-37. PubMed ID: 9413556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.
    Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
    Blood; 2004 May; 103(10):3783-8. PubMed ID: 14751930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin).
    Holmes WE; Nelles L; Lijnen HR; Collen D
    J Biol Chem; 1987 Feb; 262(4):1659-64. PubMed ID: 2433286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
    Shin JS; Yu MH
    J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate.
    Sazonova IY; Thomas BM; Gladysheva IP; Houng AK; Reed GL
    J Thromb Haemost; 2007 Oct; 5(10):2087-94. PubMed ID: 17883703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin.
    Aoki N
    Thromb Haemost; 1993 Aug; 70(2):376. PubMed ID: 8236154
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.
    Pike RN; Buckle AM; le Bonniec BF; Church FC
    FEBS J; 2005 Oct; 272(19):4842-51. PubMed ID: 16176258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why alpha-antiplasmin must be converted to a derivative form for optimal function.
    Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
    J Thromb Haemost; 2007 Oct; 5(10):2095-104. PubMed ID: 17883704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin.
    Hortin GL; Gibson BL; Fok KF
    Biochem Biophys Res Commun; 1988 Sep; 155(2):591-6. PubMed ID: 2458720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.